Article

Clinician plays critical role in diagnosis, treatment of painful ophthalmoplegia

Chicago-Painful ophthalmoplegia may be a benign condition, such as microvascular ocular motor neuropathy, most commonly seen in the elderly with head and/or face pain, not requiring neuroimaging. On the other hand, it may be more serious with a combination of signs/symptoms that indicate a problem originating in the brain stem, cavernous sinus, or elsewhere, requiring a complete work-up, explained Gregory P. Van Stavern, MD.

"When someone comes in with painful diplopia, our job [as clinicians] is to put together their signs and symptoms and see if we can point to somewhere in the brain," said Dr. Van Stavern, assistant professor of ophthalmology and neurology, Kresge Eye Institute/Wayne State University, Detroit. "Physicians have to take a good history and at least be aware of some of the relevant neuro-anatomy."

During the Neuro-Ophthalmology Subspecialty Day Meeting at the American Academy of Ophthalmology annual meeting, Dr. Van Stavern covered four possible diagnoses of painful ophthalmoplegia: microvascular ocular motor neuropathy, pituitary apoplexy, carotid-cavernous fistulas, and cavernous sinus syndrome.

A 67-year-old man who had diabetes, hypertension, and painful diplopia existing for 2 weeks before presentation was examined at Dr. Van Stavern's clinic. On examination, a complete right abduction defect was found and there were no other localizing symptoms. A microvascular sixth nerve palsy was diagnosed and the patient did not require neuroimaging.

"It can be considered as a default diagnosis or diagnosis of exclusion," Dr. Van Stavern said.

In most of these cases, patients will recover over 3 to 4 months. However, if there has been no resolution of symptoms in 1 month or the patient's condition has not resolved between 4 and 6 months, neuroimaging should be considered. The development of new, localizing symptoms also suggests the need for neuroimaging, he said.

An emergency

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.